(Q42444949)

31 October 2017

title

Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma (English)

1 reference

31 October 2017

1 reference

1

1 reference

31 October 2017

7

1 reference

31 October 2017

Roberta Fasani

3

0 references

Antonina Parafioriti

object named as

Antonina Parafioriti

6

0 references

author name string

Caterina Pellegrini

2

1 reference

31 October 2017

Marco Maggioni

4

1 reference

31 October 2017

Guido Coggi

5

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

31 October 2017

1 reference

31 October 2017

volume

34

1 reference

31 October 2017

issue

7

1 reference

31 October 2017

page(s)

639-645

1 reference

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

ErbB2 expression is correlated with increased survival of patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Reproducibility of a histopathologic grading system for adult soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Molecular characterisation of soft tissue tumours: a gene expression study

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Cytoplasmic c-erbB-2 protein expression correlates with survival in Dukes' B colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

The c-erb B-2 proto-oncogene in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2803%2900238-7

7 January 2021

10.1016/S0046-8177(03)00238-7

Identifiers

DOI

1 reference

31 October 2017

1 reference